Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Katja C. Zimmermann
Observed names:
K C Zimmermann,
K Zimmermann,
Katja C Zimmermann,
Katja Zimmermann
Institution:
Bayer (Germany)
Observed institutions:
La Jolla Institute for Immunology,
University of Groningen,
Henry Ford Hospital,
Heinrich Heine University Düsseldorf,
Bayer (Germany)
ORCID:
0000-0002-3356-8757
Observed ORCID:
0000-0002-3356-8757
OpenAlex ID:
A5022297061
The machinery of programmed cell death
2001
·
Katja C. Zimmermann
, Christine Bonzon
, et al.
·
Pharmacology & Therapeutics
·
836
Cyclooxygenase-2 expression in human esophageal carcinoma.
1999
·
K C Zimmermann
, M Sarbia
, et al.
·
PubMed
·
664
Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles
2020
·
John K. Eaton
, Laura Furst
, et al.
·
Nature Chemical Biology
·
518
PDF
How cells die: Apoptosis pathways☆☆☆
2001
·
Katja C. Zimmermann
, Douglas R. Green
·
Journal of Allergy and Clinical Immunology
·
323
PDF
The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies
2019
·
Sven Christian
, Claudia Merz
, et al.
·
Leukemia
·
259
PDF
Cyclooxygenase-2 in human platelets as a possible factor in aspirin resistance
1999
·
Artur-Aron Weber
, Katja C Zimmermann
, et al.
·
The Lancet
·
190
The role of ARK in stress-induced apoptosis in Drosophila cells
2002
·
Katja C. Zimmermann
, Jean-Ehrland Ricci
, et al.
·
The Journal of Cell Biology
·
180
Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivo
2017
·
Stefan Pusch
, Sonja Krausert
, et al.
·
Acta Neuropathologica
·
179
Crystal structures of the selenoprotein glutathione peroxidase 4 in its apo form and in complex with the covalently bound inhibitor ML162
2021
·
Dieter Moosmayer
, André Hilpmann
, et al.
·
Acta Crystallographica Section D Structural Biology
·
131
PDF
Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo
2017
·
A Chaturvedi
, L Herbst
, et al.
·
Leukemia
·
125
Constitutive Cyclooxygenase-2 Expression in Healthy Human and Rabbit Gastric Mucosa
1998
·
Katja C. Zimmermann
, Mario Sarbia
, et al.
·
Molecular Pharmacology
·
113
Aspirin Induces Apoptosis through Release of Cytochrome c from Mitochondria
2000
·
Katja C. Zimmermann
, Nigel J. Waterhouse
, et al.
·
Neoplasia
·
101
PDF
Chronic Therapy With a Partial Adenosine A1-Receptor Agonist Improves Left Ventricular Function and Remodeling in Dogs With Advanced Heart Failure
2013
·
Hani N. Sabbah
, Ramesh C. Gupta
, et al.
·
Circulation Heart Failure
·
66
PDF
Neladenoson Bialanate Hydrochloride: A Prodrug of a Partial Adenosine A1 Receptor Agonist for the Chronic Treatment of Heart Diseases
2017
·
Daniel Meibom
, Barbara Albrecht‐Küpper
, et al.
·
ChemMedChem
·
57
Augmented myocardial ischaemia by nicotine – Mechanisms and their possible significance
1998
·
Karsten Schrör
, Katja C Zimmermann
, et al.
·
British Journal of Pharmacology
·
43
PDF
Selective Attenuation of Norepinephrine Release and Stress-Induced Heart Rate Increase by Partial Adenosine A1 Agonism
2011
·
Lorenz Bott-Flügel
, Alexandra Bernshausen
, et al.
·
PLoS ONE
·
27
PDF
BAY-069, a Novel (Trifluoromethyl)pyrimidinedione-Based BCAT1/2 Inhibitor and Chemical Probe
2022
·
Judith Günther
, Roman C. Hillig
, et al.
·
Journal of Medicinal Chemistry
·
25
Pan-Mutant-IDH1 Inhibitor Bay-1436032 Is Highly Effective Against Human IDH1 Mutant Acute Myeloid Leukemia In Vivo
2016
·
Michael Heuser
, Lena Herbst
, et al.
·
Blood
·
9
Abstract 2: Discovery of BAY 2402234 by phenotypic screening: A human Dihydroorotate Dehydrogenase (DHODH) inhibitor in clinical trials for the treatment of myeloid malignancies
2019
·
Stefan N. Gradl
, Thomas Mueller
, et al.
·
Cancer Research
·
7
Abstract 13624: A Novel Chymase Inhibitor BAY 1142524 Reduces Fibrosis and Improves Cardiac Function After Myocardial Infarction in Hamster
2017
·
Hanna Tinel
, Dmitry Zubov
, et al.
·
Circulation
·
5
In the company of killers
2001
·
Katja C Zimmermann
, Michael J Pinkoski
·
Trends in Molecular Medicine
·
5
Discovery and Preclinical Characterization of Fulacimstat (BAY 1142524), a Potent and Selective Chymase Inhibitor As a New Profibrinolytic Approach for Safe Thrombus Resolution
2024
·
Chantal Fürstner
, Jens Ackerstaff
, et al.
·
Journal of Medicinal Chemistry
·
4
PDF
What’s New in European Property Law?
2022
·
Katja Zimmermann
·
European Property Law Journal
·
4
PDF
The EU Succession Certificate
2022
·
Sjef van Erp
, Katja Zimmermann
·
ERA Forum
·
4
PDF
Abstract 2: Discovery of BAY 2402234 by phenotypic screening: A human Dihydroorotate Dehydrogenase (DHODH) inhibitor in clinical trials for the treatment of myeloid malignancies
2019
·
Stefan N. Gradl
, Thomas Mueller
, et al.
·
Cancer Chemistry
·
2
Show more works
View as search
Works count:
30
Citation count:
3,881
H-index:
17
I10-index:
17
Year
Topic
Type